Company news
CTT Pharmaceutical Holdings, Inc. news in 2018
CTT Pharmaceutical Holdings, Inc.'s news releases, calls and decks from 2018, newest first.
CTT Pharmaceuticals Initiates Legal Action Against Rapid Dose Therapeutics Ltd.
October 1, 2018
Aurora Cannabis Converts CTT Pharmaceuticals Debenture into 9% Equity Position
September 11, 2018
CTT Pharmaceuticals Appoints Aurora Nominee Dr. Jason Dyck to Board of Directors
July 12, 2018
CTT Pharmaceuticals Announces Executive Management Change
June 7, 2018
CTT Pharmaceuticals Completes Strategic Investment with Aurora Cannabis Funds Earmarked for Expansion of Patent Portfolio
June 5, 2018
Aurora Cannabis Makes Strategic Investment in CTT Pharmaceutical
May 22, 2018
CTT Pharmaceutical Holdings, Inc. Provides Corporate Update with Emphasis on Patent Portfolio
May 15, 2018
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical
April 16, 2018
UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
February 21, 2018
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
February 21, 2018
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces U.S. Patent for Therapeutic Composition for Treating Psoriasis with Cannabidiol and Corticosteroids
January 10, 2018